Researchers strive to find optimal approach for reducing toxicities resulting from graft-versus-host-disease prophylaxis treatment.
New study yields clues to the cause of relapse after bone marrow transplant in patients with certain types of leukemia.
Hematopoietic stem cell transplantation requires a prolonged hospitalization and patients often face an increased risk of complications, including transplant-related mortality. Why experts say using this quality improvement model is a “powerful tool.”
Our oncologists have compiled the top 10 abstracts recently presented at the annual meeting of the
American Society of Clinical Oncology.